Network News

X My Profile
View More Activity
Posted at 10:25 AM ET, 01/17/2011

Steve Jobs to take medical leave of absence

By Washington Post editor

Apple co-founder Steve Jobs said Monday he is taking a medical leave of absence but will continue to serve as chief executive, Post reporter Cecilia Kang writes.

In a letter sent to employees Monday, Jobs said the board of directors granted him the leave so "I can focus on my health," but that he would be involved in "major strategic decisions for the company." Jobs is a survivor of pancreatic cancer.

Day-to-day operations would be taken over by Chief Operating Officer Tim Cook, who recently represented Apple during its co-launch of the iPhone with Verizon Wireless.

To read the full story on Post Tech, click here.

By Washington Post editor  | January 17, 2011; 10:25 AM ET
Categories:  Apple  
Save & Share:  Send E-mail   Facebook   Twitter   Digg   Yahoo Buzz   Del.icio.us   StumbleUpon   Technorati   Google Buzz   Previous: Verizon iPhone antenna redesign may solve death grip
Next: Stocks fall in Germany on news of Jobs's leave from Apple

Comments

So sad. Here are the facts. No matter what stage pancreatic cancer is found at, it is not curable. Find it late and you are dead in months. Find it early when it is "contained" within the pancreas and remove it and you will still die of it within roughly 5 years. Jobs has beaten the odds and lasted 7. The doctors who sold him a liver wasted it. Jobs is dying of metastatic pancreatic cancer. He has been dying of this disease since 2003. The real problem is the failure on the part of the public and the medical profession, especially the oncologists and transplant surgeons, to recognize that pancreatic cancer is fatal. There is no cure, not even in the "early" stage. The disease has micrometastases that disseminate long before the primary is evident. The medical profession continues to sell false hope.

Posted by: physicianexec | January 17, 2011 11:00 AM | Report abuse

Post a Comment

We encourage users to analyze, comment on and even challenge washingtonpost.com's articles, blogs, reviews and multimedia features.

User reviews and comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions.




characters remaining

 
 
RSS Feed
Subscribe to The Post

© 2011 The Washington Post Company